You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Histone Deacetylase Inhibitors

Showing 1 - 25 of 4,574
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)

Active, not recruiting
Has Results
  • HIV Infections
  • Birmingham, Alabama
  • +13 more
Jan 13, 2022

Heart Failure With Normal Ejection Fraction, Left Ventricular Hypertrophy, Aortic Valve Stenosis Trial in Boston

Recruiting
  • Heart Failure With Normal Ejection Fraction
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 1, 2022

Hodgkin's Lymphoma Trial in Milan (histone deacetylase inhibitor (ITF2357))

Terminated
  • Hodgkin's Lymphoma
  • histone deacetylase inhibitor (ITF2357)
  • Milan, Italy
    Istituto Nazionale per lo studio e la cura dei Tumori
Jan 18, 2022

Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Skin Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023

Hodgkin's Lymphoma Trial in Milano (ITF2357)

Completed
Has Results
  • Hodgkin's Lymphoma
  • Milano, Italy
    Istituto Nazionale per la Cura e lo Studio dei Tumori
Apr 20, 2021

Chronic Lymphocytic Leukemia Trial in Perugia (ITF2357)

Terminated
  • Chronic Lymphocytic Leukemia
  • Perugia, Italy
    Department of Internal Medicine and Public Health, University of
Jan 18, 2022

Multiple Myeloma Trial in Cagliari (ITF2357)

Terminated
  • Multiple Myeloma
  • Cagliari, Italy
    Presidio Ospedaliero R. Binaghi
Jan 18, 2022

Sarcoma Trial in Guangzhou (chidamide and toripalimab)

Recruiting
  • Sarcoma
  • chidamide and toripalimab
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Univerisity
Sep 4, 2022

Ototoxicity, Drug-Induced Trial in Cincinnati (Sodium Thiosulfate)

Recruiting
  • Ototoxicity, Drug-Induced
  • Sodium Thiosulfate
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Mar 6, 2023

Multiple Myeloma Trial in United States (ACY-1215, lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Boston, Massachusetts
  • +4 more
Feb 7, 2022

Peripheral T-cell Lymphoma Trial in Shanghai (PD-1 antibody+ HDAC inhibitor)

Recruiting
  • Peripheral T-cell Lymphoma
  • PD-1 antibody+ HDAC inhibitor
  • Shanghai, Shanghai, China
    Dongmei Ji
Dec 3, 2021

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
May 6, 2022

Histone Deacetylase (HDAC) Activity Trial in Corvallis (BSE , Garlic oil, BSE)

Terminated
Has Results
  • Histone Deacetylase (HDAC) Activity
  • BSE placebo
  • +3 more
  • Corvallis, Oregon
    Oregon State University
Apr 8, 2019

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

Multiple Myeloma Trial in Worldwide (ACY-241, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +24 more
Dec 15, 2022

Safety and Efficacy Trial in Guangzhou, Wuhan (Sintilimab, Chidamide)

Completed
  • Safety and Efficacy
  • Guangzhou, Guangdong, China
  • +3 more
Apr 6, 2022

Triple-Negative Breast Cancer, Breast Cancer Trial in United States (Romidepsin, Cisplatin, Nivolumab)

Active, not recruiting
  • Triple-Negative Breast Cancer
  • Breast Cancer
  • Fairway, Kansas
  • +6 more
Nov 19, 2021

Cervical Cancer, Cervix Cancer, Cervix Tumor Trial in Guangzhou (Toripalimab + Chidamide)

Recruiting
  • Cervical Cancer
  • +2 more
  • Toripalimab + Chidamide
  • Guangzhou, 广东, China
    Sun Yat-sen University Cancer Centre
Dec 3, 2020

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

Lymphoma, Follicular Trial in China (Abexinostat)

Recruiting
  • Lymphoma, Follicular
  • Beijing, China
  • +25 more
Mar 3, 2022

Cutaneous T-Cell Lymphoma, Mature T-cell Malignancies, Peripheral T-Cell Lymphoma Trial run by the NCI (Romidepsin,

Recruiting
  • Cutaneous T-Cell Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Relapsed or Refractory Multiple Myeloma Trial (Vorinostat, Bortezomib, Dexamethasone)

Completed
Has Results
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Mar 5, 2021

Circulating Tumor DNA-Guided Late-Line Treatment in Late-Stage

Completed
  • Metastatic Breast Cancer
  • +2 more
  • Control group
  • Case group
  • (no location specified)
Jun 16, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

Recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • New Haven, Connecticut
    Yale University Cancer Center LAO
Jun 29, 2022

GVHD, GVHD Trial in Tampa (Panobinostat, Sirolimus, Tacrolimus)

Completed
Has Results
  • Graft Versus Host Disease
  • GVHD
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jul 19, 2021